{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T21:15:34Z","timestamp":1790716534671,"version":"4.1.0"},"reference-count":65,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","rbmojournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Reproductive BioMedicine Online"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1016\/j.rbmo.2016.07.010","type":"journal-article","created":{"date-parts":[[2016,8,5]],"date-time":"2016-08-05T03:37:56Z","timestamp":1470368276000},"page":"436-448","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":51,"title":["Ovarian function during hormonal contraception assessed by endocrine and sonographic markers: a systematic review"],"prefix":"10.1016","volume":"33","author":[{"given":"Stella","family":"D'Arpe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mara","family":"Di Feliciantonio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miriam","family":"Candelieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Franceschetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Grazia","family":"Piccioni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Bastianelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.rbmo.2016.07.010_bib0010","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1067\/mob.2000.104233","article-title":"Prevalence of enlarged ovarian follicles among users of levonorgestrel subdermal contraceptive implants (Norplant)","volume":"182","author":"Alvarez-Sanchez","year":"2000","journal-title":"Am. J. Obstet. Gynecol"},{"key":"10.1016\/j.rbmo.2016.07.010_bib0015","doi-asserted-by":"crossref","first-page":"3192","DOI":"10.1093\/humrep\/dem258","article-title":"Serum anti-mullerian hormone levels and follicular cohort characteristics after pituitary suppression in the late luteal phase with oral contraceptive pills","volume":"22","author":"Arbo","year":"2007","journal-title":"Hum. Reprod"},{"key":"10.1016\/j.rbmo.2016.07.010_bib0020","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.contraception.2009.03.006","article-title":"Ovarian activity and safety of a novel levonorgestrel\/ethinyl estradiol continuous oral contraceptive regimen","volume":"80","author":"Archer","year":"2009","journal-title":"Contraception"},{"key":"10.1016\/j.rbmo.2016.07.010_bib0025","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S1701-2163(16)30692-2","article-title":"Ovarian follicular development during the use of oral contraception: a review","volume":"26","author":"Baerwald","year":"2004","journal-title":"J. Obstet. Gynaecol. Can"},{"key":"10.1016\/j.rbmo.2016.07.010_bib0030","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.contraception.2004.05.006","article-title":"Ovarian follicular development is initiated during the hormone-free interval of oral contraceptive use","volume":"70","author":"Baerwald","year":"2004","journal-title":"Contraception"},{"key":"10.1016\/j.rbmo.2016.07.010_bib0035","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/S0015-0282(97)81906-1","article-title":"Neuroendocrine mechanism of anovulation in users of contraceptive subdermal implant of nomegestrol acetate (uniplant)","volume":"67","author":"Barnhart","year":"1997","journal-title":"Fertil. Steril"},{"key":"10.1016\/j.rbmo.2016.07.010_bib0040","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.rbmo.2012.09.001","article-title":"Ovarian reserve parameters: a comparison between users and non-users of hormonal contraception","volume":"25","author":"Bentzen","year":"2012","journal-title":"Reprod. Biomed. Online"},{"key":"10.1016\/j.rbmo.2016.07.010_bib0045","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.contraception.2005.09.009","article-title":"Ovarian follicular dynamics during conventional vs. continuous oral contraceptive use","volume":"73","author":"Birtch","year":"2006","journal-title":"Contraception"},{"key":"10.1016\/j.rbmo.2016.07.010_bib0050","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0010-7824(99)00028-1","article-title":"Timing of onset of contraceptive effectiveness in Norplant implant users. II. Effect on the ovarian function in the first cycle of use","volume":"59","author":"Brache","year":"1999","journal-title":"Contraception"},{"key":"10.1016\/j.rbmo.2016.07.010_bib0055","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S0010-7824(00)00092-5","article-title":"Ovarian function during use of Nestorone(R) subdermal implants","volume":"61","author":"Brache","year":"2000","journal-title":"Contraception"},{"key":"10.1016\/j.rbmo.2016.07.010_bib0060","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/0010-7824(95)00127-V","article-title":"Enlarged follicles in women using oral contraceptives","volume":"52","author":"Broome","year":"1995","journal-title":"Contraception"},{"key":"10.1016\/j.rbmo.2016.07.010_bib0065","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0010-7824(02)00344-X","article-title":"The effect of extending the pill-free interval on follicular activity: triphasic norgestimate\/35 micro g ethinyl estradiol versus monophasic levonorgestrel\/20 micro g ethinyl estradiol","volume":"66","author":"Creinin","year":"2002","journal-title":"Contraception"},{"key":"10.1016\/j.rbmo.2016.07.010_bib0070","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S0010-7824(96)00178-3","article-title":"Ovarian activity during regular oral contraceptive use","volume":"54","author":"Crosignani","year":"1996","journal-title":"Contraception"},{"key":"10.1016\/j.rbmo.2016.07.010_bib0075","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1002\/uog.10114","article-title":"Quantifying effect of combined oral contraceptive pill on functional ovarian reserve as measured by serum anti-M\u00fcllerian hormone and small antral follicle count using three-dimensional ultrasound","volume":"39","author":"Deb","year":"2012","journal-title":"Ultrasound Obstet. Gynecol"},{"key":"10.1016\/j.rbmo.2016.07.010_bib0080","doi-asserted-by":"crossref","first-page":"2668","DOI":"10.1093\/humrep\/deh493","article-title":"Ovarian function with the contraceptive vaginal ring or an oral contraceptive: a randomized study","volume":"19","author":"Duijkers","year":"2004","journal-title":"Hum. Reprod"},{"key":"10.1016\/j.rbmo.2016.07.010_bib0085","doi-asserted-by":"crossref","first-page":"419","DOI":"10.3109\/13625187.2015.1044082","article-title":"A randomised study comparing the effect on ovarian activity of a progestogen-only pill (POP) containing desogestrel and a new POP containing drospirenone in a 24\/4 regimen","volume":"20","author":"Duijkers","year":"2015","journal-title":"Eur. J. Contracept. Reprod. Health Care"},{"key":"10.1016\/j.rbmo.2016.07.010_bib0090","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/0010-7824(95)00096-S","article-title":"Ovarian function during low-dose oral contraceptive use","volume":"51","author":"Egarter","year":"1995","journal-title":"Contraception"},{"key":"10.1016\/j.rbmo.2016.07.010_bib0095","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0002-9378(98)70249-2","article-title":"Omitting the first oral contraceptive pills of the cycle does not automatically lead to ovulation","volume":"179","author":"Elomaa","year":"1998","journal-title":"Am. J. Obstet. Gynecol"},{"key":"10.1016\/j.rbmo.2016.07.010_bib0100","first-page":"71","article-title":"Manipulation of human ovarian function: physiological concepts and clinical consequences","volume":"18","author":"Fauser","year":"1997","journal-title":"Endocr. Rev"},{"key":"10.1016\/j.rbmo.2016.07.010_bib0105","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/BF01986524","article-title":"A comparison of the effects of two monophasic low dose oral contraceptives on the inhibition of ovulation","volume":"10","author":"Fitzgerald","year":"1994","journal-title":"Adv. Contracept"},{"key":"10.1016\/j.rbmo.2016.07.010_bib0110","first-page":"29","article-title":"Ovulation and follicular development associated with three low-dose oral contraceptives: a randomized controlled trial","volume":"83","author":"Grimes","year":"1994","journal-title":"Obstet. Gynecol"},{"key":"10.1016\/j.rbmo.2016.07.010_bib0115","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1080\/13625180400008940","article-title":"Combined ethinylestradiol\/gestodene contraceptive patch: two-center, open-label study of ovulation inhibition, acceptability and safety over two cycles in female volunteers","volume":"9","author":"Heger-Mahn","year":"2004","journal-title":"Eur. J. Contracept. Reprod. Health Care"},{"key":"10.1016\/j.rbmo.2016.07.010_bib0120","first-page":"529","article-title":"Functional ovarian cysts in relation to the use of monophasic and triphasic oral contraceptives","volume":"79","author":"Holt","year":"1992","journal-title":"Obstet. Gynecol"},{"key":"10.1016\/j.rbmo.2016.07.010_bib0125","first-page":"252","article-title":"Oral contraceptives, tubal sterilization, and functional ovarian cyst risk","volume":"102","author":"Holt","year":"2003","journal-title":"Obstet. Gynecol"},{"key":"10.1016\/j.rbmo.2016.07.010_bib0130","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/0010-7824(93)90025-3","article-title":"Ultrasound evaluation of ovarian activity under oral contraceptives","volume":"47","author":"Hoogland","year":"1993","journal-title":"Contraception"},{"key":"10.1016\/j.rbmo.2016.07.010_bib0135","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.contraception.2011.12.013","article-title":"Ovarian size and vascularization as assessed by three-dimensional grayscale and power Doppler ultrasound in asymptomatic women 20\u201339 years old using combined oral contraceptives","volume":"86","author":"Jokubkiene","year":"2012","journal-title":"Contraception"},{"key":"10.1016\/j.rbmo.2016.07.010_bib0140","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1016\/j.fertnstert.2012.11.034","article-title":"Antimullerian hormone levels decrease in women using combined contraception independently of administration route","volume":"99","author":"Kallio","year":"2013","journal-title":"Fertil. Steril"},{"key":"10.1016\/j.rbmo.2016.07.010_bib0145","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/S0002-9378(98)70292-3","article-title":"Ovarian activity in women taking an oral contraceptive containing 20 microg ethinyl estradiol and 150 microg desogestrel: effects of low estrogen doses during the hormone-free interval","volume":"179","author":"Killick","year":"1998","journal-title":"Am. J. Obstet. Gynecol"},{"key":"10.1016\/j.rbmo.2016.07.010_bib0150","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1095\/biolreprod45.6.890","article-title":"Early folliculogenesis in primate ovaries: testing the role of estrogen","volume":"45","author":"Koering","year":"1991","journal-title":"Biol. Reprod"},{"key":"10.1016\/j.rbmo.2016.07.010_bib0155","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1095\/biolreprod50.3.686","article-title":"Early follicle growth in the juvenile macaca monkey ovary: the effects of estrogen priming and follicle-stimulating hormone","volume":"50","author":"Koering","year":"1994","journal-title":"Biol. Reprod"},{"key":"10.1016\/j.rbmo.2016.07.010_bib0160","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/j.fertnstert.2011.12.017","article-title":"The association between circulating levels of antimullerian hormone and follicle number, androgens, and menstrual cycle characteristics in young women","volume":"97","author":"Kristensen","year":"2012","journal-title":"Fertil. Steril"},{"key":"10.1016\/j.rbmo.2016.07.010_bib0165","doi-asserted-by":"crossref","first-page":"249","DOI":"10.3109\/13625187.2014.979282","article-title":"A phase 1, multicentre, open-label study to evaluate ovarian follicular activity and hormone levels with an extended-regimen combined oral contraceptive with low-dose ethinyl estradiol supplementation","volume":"20","author":"Kroll","year":"2015","journal-title":"Eur. J. Contracept. Reprod. Health Care"},{"key":"10.1016\/j.rbmo.2016.07.010_bib0170","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/0010-7824(80)90142-0","article-title":"Hormonal effects of the 300\u2009\u00b5g norethisterone (NET) minipill","volume":"21","author":"Landgren","year":"1980","journal-title":"Contraception"},{"key":"10.1016\/j.rbmo.2016.07.010_bib0175","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/0002-9378(92)91371-G","article-title":"Oral contraceptive type and functional ovarian cysts","volume":"166","author":"Lanes","year":"1992","journal-title":"Am. J. Obstet. Gynecol"},{"key":"10.1016\/j.rbmo.2016.07.010_bib0180","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1210\/jc.2007-2287","article-title":"Effects of continuous versus cyclical oral contraception: a randomized controlled trial","volume":"93","author":"Legro","year":"2008","journal-title":"J. Clin. Endocrinol. Metab"},{"key":"10.1016\/j.rbmo.2016.07.010_bib0185","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.contraception.2010.09.007","article-title":"Serum anti-m\u00fcllerian hormone level is not altered in women using hormonal contraceptives","volume":"83","author":"Li","year":"2011","journal-title":"Contraception"},{"key":"10.1016\/j.rbmo.2016.07.010_bib0190","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/S0015-0282(98)00015-6","article-title":"Ovarian function during the use of a single contraceptive implant: implanon compared with Norplant","volume":"69","author":"M\u00e4k\u00e4r\u00e4inen","year":"1998","journal-title":"Fertil. Steril"},{"issue":"Suppl. 1","key":"10.1016\/j.rbmo.2016.07.010_bib0195","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1016\/0010-7824(94)90113-9","article-title":"Progestin-only oral contraception: a comprehensive review","volume":"50","author":"McCann","year":"1994","journal-title":"Contraception"},{"key":"10.1016\/j.rbmo.2016.07.010_bib0200","doi-asserted-by":"crossref","first-page":"2594","DOI":"10.1093\/humrep\/17.10.2594","article-title":"Ovarian function with a novel combined contraceptive vaginal ring","volume":"17","author":"Mulders","year":"2002","journal-title":"Hum. Reprod"},{"key":"10.1016\/j.rbmo.2016.07.010_bib0205","doi-asserted-by":"crossref","first-page":"587","DOI":"10.3109\/09513590.2010.507283","article-title":"The impact of oral contraceptives and metformin on anti-M\u00fcllerian hormone serum levels in women with polycystic ovary syndrome and biochemical hyperandrogenemia","volume":"27","author":"Panidis","year":"2011","journal-title":"Gynecol. Endocrinol"},{"key":"10.1016\/j.rbmo.2016.07.010_bib0210","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/S0015-0282(98)00309-4","article-title":"Timing of onset of contraceptive effectiveness in Depo-Provera users. II. Effects on ovarian function","volume":"70","author":"Petta","year":"1998","journal-title":"Fertil. Steril"},{"key":"10.1016\/j.rbmo.2016.07.010_bib0215","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/S0015-0282(01)01672-7","article-title":"Delayed first injection of the once-a-month injectable contraceptive containing 25\u2009mg of medroxyprogesterone acetate and 5\u2009mg of E(2)-cypionate: effects on ovarian function","volume":"75","author":"Petta","year":"2001","journal-title":"Fertil. Steril"},{"key":"10.1016\/j.rbmo.2016.07.010_bib0220","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/S0015-0282(03)00556-9","article-title":"Ortho Evra\/Evra versus oral contraceptives: follicular development and ovulation in normal cycles and after an intentional dosing error","volume":"80","author":"Pierson","year":"2003","journal-title":"Fertil. Steril"},{"key":"10.1016\/j.rbmo.2016.07.010_bib0225","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1080\/13625189709049933","article-title":"The effects of monophasic and triphasic oral contraceptives on ovarian function and endometrial thickness","volume":"2","author":"Rabe","year":"1997","journal-title":"Eur. J. Contracept. Reprod. Health Care"},{"key":"10.1016\/j.rbmo.2016.07.010_bib0230","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.contraception.2008.10.005","article-title":"Follicular development in a 7-day versus 4-day hormone-free interval with an oral contraceptive containing 20\u2009mcg ethinyl estradiol and 1\u2009mg norethindrone acetate","volume":"79","author":"Rible","year":"2009","journal-title":"Contraception"},{"key":"10.1016\/j.rbmo.2016.07.010_bib0235","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0010-7824(97)00070-X","article-title":"A comparative randomized trial on the impact of two low-dose oral contraceptives on ovarian activity, cervical permeability, and endometrial receptivity","volume":"56","author":"Rossmanith","year":"1997","journal-title":"Contraception"},{"key":"10.1016\/j.rbmo.2016.07.010_bib0240","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/j.ajog.2004.02.012","article-title":"Manipulation of the pill-free interval in oral contraceptive pill users: the effect on follicular suppression","volume":"190","author":"Schlaff","year":"2004","journal-title":"Am. J. Obstet. Gynecol"},{"key":"10.1016\/j.rbmo.2016.07.010_bib0245","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.contraception.2015.03.001","article-title":"Ovulatory effects of three oral contraceptive regimens: a randomized, open-label, descriptive trial","volume":"91","author":"Seidman","year":"2015","journal-title":"Contraception"},{"key":"10.1016\/j.rbmo.2016.07.010_bib0250","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.fertnstert.2007.02.014","article-title":"Mullerian Inhibiting Substance is an ovarian growth factor of emerging clinical significance","volume":"88","author":"Seifer","year":"2007","journal-title":"Fertil. Steril"},{"key":"10.1016\/j.rbmo.2016.07.010_bib0255","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/S0015-0282(16)55917-2","article-title":"Sonographic assessment of ovarian and endometrial changes during long-term Norplant use and their correlation with hormonal levels","volume":"59","author":"Shaaban","year":"1993","journal-title":"Fertil. Steril"},{"key":"10.1016\/j.rbmo.2016.07.010_bib0260","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.ejogrb.2007.01.012","article-title":"Anti-mullerian hormone levels during hormonal contraception in women with polycystic ovary syndrome","volume":"134","author":"Somunkiran","year":"2007","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol"},{"key":"10.1016\/j.rbmo.2016.07.010_bib0265","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/0002-9378(80)90393-2","article-title":"Pituitary and ovarian responsiveness to a graded gonadotropin releasing factor stimulation test in women using a low-estrogen or a regular type of oral contraceptive","volume":"137","author":"Spellacy","year":"1980","journal-title":"Am. J. Obstet. Gynecol"},{"key":"10.1016\/j.rbmo.2016.07.010_bib0270","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/0010-7824(96)00137-0","article-title":"Shorter pill-free interval in combined oral contraceptives decreases follicular development","volume":"54","author":"Spona","year":"1996","journal-title":"Contraception"},{"key":"10.1016\/j.rbmo.2016.07.010_bib0275","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1016\/j.fertnstert.2009.06.057","article-title":"Suppression of ovarian function by a combined oral contraceptive containing 0.02\u2009mg ethinyl estradiol and 2\u2009mg chlormadinone acetate given in a 24\/4-day intake regimen over three cycles","volume":"94","author":"Spona","year":"2010","journal-title":"Fertil. Steril"},{"key":"10.1016\/j.rbmo.2016.07.010_bib0280","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.fertnstert.2007.06.023","article-title":"Serum antimullerian hormone levels remain stable throughout the menstrual cycle and after oral or vaginal administration of synthetic sex steroids","volume":"90","author":"Streuli","year":"2008","journal-title":"Fertil. Steril"},{"key":"10.1016\/j.rbmo.2016.07.010_bib0285","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0015-0282(99)00205-8","article-title":"Effect of 21-day and 24-day oral contraceptive regimens containing gestodene (60 microg) and ethinyl estradiol (15 microg) on ovarian activity","volume":"72","author":"Sullivan","year":"1999","journal-title":"Fertil. Steril"},{"key":"10.1016\/j.rbmo.2016.07.010_bib0290","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S0015-0282(16)44590-5","article-title":"Effects of progestin-estrogen combination and progestational contraceptives on pituitary gonadotropins, gonadal steroids and sex hormone-binding globulin","volume":"33","author":"Tafurt","year":"1980","journal-title":"Fertil. Steril"},{"key":"10.1016\/j.rbmo.2016.07.010_bib0295","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1111\/j.1471-0528.1985.tb02994.x","article-title":"Ultrasound demonstration of increased frequency of functional ovarian cysts in women using progestogen-only oral contraception","volume":"92","author":"Tayob","year":"1985","journal-title":"Br. J. Obstet. Gynaecol"},{"key":"10.1016\/j.rbmo.2016.07.010_bib0300","doi-asserted-by":"crossref","first-page":"299","DOI":"10.3109\/09513599509160463","article-title":"The influence of the dose of ethinylestradiol in oral contraceptives on follicle growth","volume":"9","author":"Teichmann","year":"1995","journal-title":"Gynecol. Endocrinol"},{"key":"10.1016\/j.rbmo.2016.07.010_bib0305","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1093\/humrep\/deq071","article-title":"Comparison of ovarian function markers in users of hormonal contraceptives during the hormone free interval and subsequent natural early follicular phases","volume":"25","author":"Van den Berg","year":"2010","journal-title":"Hum. Reprod"},{"key":"10.1016\/j.rbmo.2016.07.010_bib0310","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/0010-7824(95)00228-6","article-title":"Ovarian activity suppression by two different low-dose triphasic oral contraceptives","volume":"52","author":"Van der Does","year":"1995","journal-title":"Contraception"},{"key":"10.1016\/j.rbmo.2016.07.010_bib0315","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0010-7824(99)00025-6","article-title":"Activity of the pituitary-ovarian axis in the pill-free interval during use of low-dose combined oral contraceptives","volume":"59","author":"Van Heusden","year":"1999","journal-title":"Contraception"},{"key":"10.1016\/j.rbmo.2016.07.010_bib0320","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.contraception.2007.11.005","article-title":"Evaluation of pituitary-ovarian axis suppression with three oral contraceptive regimens","volume":"77","author":"Vandever","year":"2008","journal-title":"Contraception"},{"key":"10.1016\/j.rbmo.2016.07.010_bib0325","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/0010-7824(81)90035-4","article-title":"Pituitary response to LHRH stimulation in women on oral contraceptives: a follow up dose response study","volume":"24","author":"Wan","year":"1981","journal-title":"Contraception"},{"key":"10.1016\/j.rbmo.2016.07.010_bib0330","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/S0002-9378(11)91570-1","article-title":"A randomized, double-blind, placebo-controlled comparison of the impact of low-dose and triphasic oral contraceptives on follicular development","volume":"167","author":"Young","year":"1992","journal-title":"Am. J. Obstet. Gynecol"}],"container-title":["Reproductive BioMedicine Online"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1472648316304412?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1472648316304412?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,9]],"date-time":"2018-09-09T12:22:22Z","timestamp":1536495742000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1472648316304412"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10]]},"references-count":65,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,10]]}},"alternative-id":["S1472648316304412"],"URL":"https:\/\/doi.org\/10.1016\/j.rbmo.2016.07.010","relation":{},"ISSN":["1472-6483"],"issn-type":[{"value":"1472-6483","type":"print"}],"subject":[],"published":{"date-parts":[[2016,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ovarian function during hormonal contraception assessed by endocrine and sonographic markers: a systematic review","name":"articletitle","label":"Article Title"},{"value":"Reproductive BioMedicine Online","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rbmo.2016.07.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Reproductive Healthcare Ltd. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}